Microdomains in the cardiovascular system
The book comprehensively presents new findings in cardiovascular research related to signaling microdomains in health and disease. Important second messengers such as cAMP, cGMP, calcium and their role in microdomain signaling are discussed. The book offers and explains methodical approaches and tec...
Saved in:
Other Authors: | , |
---|---|
Format: | eBook |
Language: | English |
Published: |
Cham :
Springer,
©2017.
|
Series: | Cardiac and vascular biology.
|
Subjects: | |
ISBN: | 9783319545790 9783319545783 |
Physical Description: | 1 online resource |
LEADER | 05904cam a2200529Ii 4500 | ||
---|---|---|---|
001 | 97522 | ||
003 | CZ-ZlUTB | ||
005 | 20240914110637.0 | ||
006 | m o d | ||
007 | cr |n||||||||| | ||
008 | 170926s2017 sz ob 000 0 eng d | ||
040 | |a YDX |b eng |e rda |e pn |c YDX |d N$T |d EBLCP |d GW5XE |d N$T |d NJR |d AZU |d UPM |d COO |d COD |d NOC |d MERER |d SNK |d OCLCQ |d CAUOI |d OCLCQ |d OCLCO |d IOG |d OCLCF |d KSU |d VT2 |d U3W |d OHI |d INT |d OCLCQ |d WYU |d OCLCQ |d LVT |d OCL |d UKMGB |d OCLCQ |d AUD |d UKAHL |d OCLCQ | ||
020 | |a 9783319545790 |q (electronic bk.) | ||
020 | |z 9783319545783 | ||
024 | 7 | |a 10.1007/978-3-319-54579-0 |2 doi | |
035 | |a (OCoLC)1004725596 |z (OCoLC)1004423974 |z (OCoLC)1004834123 |z (OCoLC)1008874684 |z (OCoLC)1011943449 |z (OCoLC)1048123904 |z (OCoLC)1066478748 | ||
245 | 0 | 0 | |a Microdomains in the cardiovascular system / |c Viacheslav Nikolaev, Manuela Zaccolo, editors. |
264 | 1 | |a Cham : |b Springer, |c ©2017. | |
300 | |a 1 online resource | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a počítač |b c |2 rdamedia | ||
338 | |a online zdroj |b cr |2 rdacarrier | ||
490 | 1 | |a Cardiac and vascular biology, |x 2509-7830 | |
504 | |a Includes bibliographical references. | ||
505 | 0 | |a Preface; Contents; Part I: Cyclic Nucleotide Microdomains; 1: Receptor-Cyclic Nucleotide Microdomains in the Heart; 1.1 Introduction; 1.2 Biosensors for cAMP and cGMP; 1.3 Mechanisms of Compartmentation in Microdomains; 1.4 Receptor-cAMP/cGMP Microdomain Visualization; References; 2: Membrane Microdomains and cAMP Compartmentation in Cardiac Myocytes; 2.1 Introduction; 2.2 Membrane Microdomains; 2.3 Receptor-Mediated Responses; 2.3.1 ß1-Adrenergic Receptors (ß1ARs); 2.3.2 ß2-Adrenergic Receptors (ß2ARs); 2.3.3 M2 Muscarinic Receptors (M2Rs); 2.3.4 Prostaglandin Receptors (EPRs). | |
505 | 8 | |a 5: Chatting Second Messengers: PIP3 and cAMP; 5.1 Introduction; 5.2 PIP3: A Signaling Lipid on Membranes; 5.3 Mechanisms of Cross-Talk between PIP3 and cAMP Signaling; 5.3.1 PIP3-Mediated Downregulation of ß-AR/cAMP Signaling in Heart Failure; 5.3.2 PIP3- and PI3K-Dependent Control of cAMP Hydrolysis; 5.3.3 cAMP-Mediated Regulation of PIP3 Signaling; References; 6: Cyclic Nucleotide Phosphodiesterases and Compartmentation in Normal and Diseased Heart; 6.1 Introduction; 6.2 CN Signalling in Cardiac Myocytes; 6.3 Overview of the PDE Superfamily. | |
505 | 8 | |a 2.4 Conclusions and Future Directions; References; 3: Function to Failure: Compartmentalization of Cardiomyocyte Signaling by A-Kinase-ƯAnchoring Proteins; 3.1 Introduction; 3.2 AKAPs and Regulation of the Calcium Cycle; 3.2.1 AKAP7 (Small Isoforms); 3.2.2 AKAP7 (Large); 3.2.3 AKAP5 (AKAP75/AKAP79/AKAP150); 3.3 AKAPs and Cardiac Remodeling; 3.3.1 AKAP6; 3.3.2 AKAP13; 3.4 Other AKAPs with Characterized Functions; References; 4: Pharmacological Approaches for Delineating Functions of AKAP-ƯBased Signalling Complexes and Finding Therapeutic Targets; 4.1 Introduction. | |
505 | 8 | |a 4.1.1 The cAMP Signalling Cascade; 4.1.2 cAMP Effectors; 4.1.3 cAMP Signalling Compartments; 4.2 A-Kinase Anchoring Proteins (AKAPs); 4.2.1 AKAP-PKA Interactions; 4.2.2 The Role of AKAPs in the Heart and Cardiovascular Diseases Exemplifies Their Potential Value as Drug Targets; 4.3 AKAP-PKA Disruptors; 4.3.1 Peptides; 4.3.1.1 Binding to R-Subunits of PKA; 4.3.1.2 Binding to AKB Domains of AKAPs; 4.3.1.3 Modified Peptides; 4.3.2 Peptidomimetics; 4.3.3 Small Molecules; 4.3.4 Disruptors of Interaction Between AKAPs and Proteins Other Than PKA; 4.4 Conclusions and Outlook; References. | |
505 | 8 | |a 6.4 Role of PDEs in Cyclic Nucleotide Compartmentation; 6.5 PDEs and Cyclic Nucleotide Compartmentation in Heart Failure; 6.6 PDEs as Therapeutic Targets in Ischemia/Reperfusion Injury?; 6.7 Concluding Remarks; References; 7: cAMP Compartmentalisation and Hypertrophy of the Heart: 'Good' Pools of cAMP and 'Bad' Pools of cAMP Coexist in the Same Cardiac Myocyte; 7.1 cAMP Signalling in the Heart; 7.2 Compartmentalisation of the cAMP Signalling Pathway; 7.3 Compartmentalisation of GPCRs and ACs; 7.4 PKA Compartmentalisation via AKAPs; 7.5 PDEs and cAMP Compartmentalisation. | |
506 | |a Plný text je dostupný pouze z IP adres počítačů Univerzity Tomáše Bati ve Zlíně nebo vzdáleným přístupem pro zaměstnance a studenty | ||
520 | |a The book comprehensively presents new findings in cardiovascular research related to signaling microdomains in health and disease. Important second messengers such as cAMP, cGMP, calcium and their role in microdomain signaling are discussed. The book offers and explains methodical approaches and technical ways how to successfully analyze microdomain signaling, also in the context of disease. It further provides scientific perspectives and strategies that are based on the concept of signaling within microdomains and that can revolutionize pharmacology and eventually lead to the effective treatment of cardiovascular diseases in future. This book is written for scientists in cardiovascular research, pharmacology, molecular and cellular biology as well as medical doctors in cardiology, angiology and nephrology. | ||
590 | |a SpringerLink |b Springer Complete eBooks | ||
650 | 0 | |a Cardiovascular system |x Physiology. | |
650 | 0 | |a Cardiovascular system |x Molecular aspects. | |
650 | 0 | |a Human physiology. | |
650 | 0 | |a Cytology. | |
650 | 0 | |a Pharmacology. | |
655 | 7 | |a elektronické knihy |7 fd186907 |2 czenas | |
655 | 9 | |a electronic books |2 eczenas | |
700 | 1 | |a Nikolaev, Viacheslav. | |
700 | 1 | |a Zaccolo, Manuela. | |
776 | 0 | 8 | |i Print version: |t Microdomains in the cardiovascular system. |d Cham : Springer, ©2017 |z 3319545787 |z 9783319545783 |w (OCoLC)971041303 |
830 | 0 | |a Cardiac and vascular biology. | |
856 | 4 | 0 | |u https://proxy.k.utb.cz/login?url=https://link.springer.com/10.1007/978-3-319-54579-0 |y Plný text |
992 | |c NTK-SpringerBLS | ||
999 | |c 97522 |d 97522 | ||
993 | |x NEPOSILAT |y EIZ |